SureTrader
Interactive Brokers Advertisement
Home > Boards > US OTC > Cannabis > Mym Nutraceuticals (MYMMF)

NEWS RELEASE 5 AprilMYM Nutraceuticals to develop the

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
MrCheap Member Profile
Member Level 
Followed By 158
Posts 17,523
Boards Moderated 8
Alias Born 03/18/14
160x600 placeholder
MrCheap Member Level  Friday, 05/05/17 09:07:08 AM
Re: None
Post # of 2608 
NEWS RELEASE 5 AprilMYM Nutraceuticals to develop the cannabis “gold standard” for product testing process and technology in Canada
MYM Nutraceuticals to develop the cannabis “gold standard” for product testing process and technology in Canada.
Vancouver, British Columbia, Canada, April 5th, 2017 – MYM Nutraceuticals Inc. (CSE:MYM) (OTC:MYMMS)(FRA:OMY), (the “Company” or “MYM”) is looking to lead the Canadian market by establishing the gold standard in quality assurance testing of its cannabis products. MYM has hired TheraCann Canada to implement its full suite of services including ISO 17025(2005) compliance to ensure repeatable and reliable data stands behind each product label. TheraCann Canada is also providing TheraCannSYSTEM software to MYM which directly captures all testing and analysis data to better control regulatory compliance concerns and future audits by Health Canada.
With the recent announcement that the Canadian Provinces to be able to decide how cannabis will be distributed within their borders, the federal government will oversee all medical and recreational marijuana cultivation. MYM is planning to jump ahead of the curve on future legislation to focus on in-house quality assurance testing laboratories and analytics.
Brent McNiven, President of, TheraCann Canada commented: With the recent flurry of dangerous recalls in the Canadian market due, in part, to a lack of tighter government control on standards, we expect Health Canada will finally be moving to a stronger and more regulated testing procedure in advance of recreational legalization. TheraCann’s “gold standard” process build on ISO 17025 (2005) will meet or exceed all future regulations and ensure MYM is ready to excel in this rapidly expanding market.
Jonathan Fiteni, MYM CEO, commented: MYM is looking to build the industry standard in all-inclusive cannabis facilities to meet the demands of the Canadian consumer. With the anticipated start of recreational legalization coming online in the summer of 2018, MYM will be positioned to provide the safest products in the market.


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist